Cargando…

The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040

BACKGROUND: Bladder cancer (BCa) is one of the most common urological malignancies worldwide. This study examines the global epidemiological profile of BCa incidence and mortality in 2020 and the projected burden to 2040. METHODS: The estimated number of BCa cases and deaths were extracted from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanting, Rumgay, Harriet, Li, Mengmeng, Yu, Haibing, Pan, Haiyan, Ni, Jindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502766/
https://www.ncbi.nlm.nih.gov/pubmed/37712386
http://dx.doi.org/10.7189/jogh.13.04109
_version_ 1785106388895137792
author Zhang, Yanting
Rumgay, Harriet
Li, Mengmeng
Yu, Haibing
Pan, Haiyan
Ni, Jindong
author_facet Zhang, Yanting
Rumgay, Harriet
Li, Mengmeng
Yu, Haibing
Pan, Haiyan
Ni, Jindong
author_sort Zhang, Yanting
collection PubMed
description BACKGROUND: Bladder cancer (BCa) is one of the most common urological malignancies worldwide. This study examines the global epidemiological profile of BCa incidence and mortality in 2020 and the projected burden to 2040. METHODS: The estimated number of BCa cases and deaths were extracted from the GLOBOCAN 2020 database. Age-standardised incidence rates (ASIRs) and age-standardised mortality rates (ASMRs) were calculated using the world standard. The predicted BCa incidence and mortality in 2040 was calculated based on demographic projections. RESULTS: Globally, approximately 573 000 new BCa cases and 213 000 deaths occurred in 2020, corresponding to ASIRs and ASMRs of 5.6 and 1.9 per 100 000, respectively. The incidence and mortality rates were approximately 4-fold higher in men (9.5 and 3.3 per 100 000, respectively) than women (2.4 and 0.9, respectively). Across world regions, incidence rates varied at least 12-fold among men and 8-fold among women, with the highest ASIRs for both men and women detected in Southern Europe (26.5 and 5.8 per 100 000, respectively) and Western Europe (21.5 and 5.8, respectively) and the lowest in Middle Africa (2.2) in men and South-Central Asia (0.7) in women. The highest ASMRs for both men and women were found in Northern Africa (9.2 and 1.8 per 100 000, respectively). By 2040, the annual number of new BCa cases and deaths will increase to 991 000 (72.8% increase from 2020) and 397 000 (86.6% increase), respectively. CONCLUSIONS: Geographical distributions of BCa incidence and mortality uncovered higher risk of BCa incidence in Southern and Western European populations and higher risk of mortality in Northern African populations. Considering the predicted 73% and 87% increase in annual BCa cases and deaths by 2040 globally, respectively, there is an urgent need to develop and accelerate BCa control initiatives for high-risk populations to tackle global BCa burden and narrow its geographical disparities.
format Online
Article
Text
id pubmed-10502766
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Society of Global Health
record_format MEDLINE/PubMed
spelling pubmed-105027662023-09-16 The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040 Zhang, Yanting Rumgay, Harriet Li, Mengmeng Yu, Haibing Pan, Haiyan Ni, Jindong J Glob Health Articles BACKGROUND: Bladder cancer (BCa) is one of the most common urological malignancies worldwide. This study examines the global epidemiological profile of BCa incidence and mortality in 2020 and the projected burden to 2040. METHODS: The estimated number of BCa cases and deaths were extracted from the GLOBOCAN 2020 database. Age-standardised incidence rates (ASIRs) and age-standardised mortality rates (ASMRs) were calculated using the world standard. The predicted BCa incidence and mortality in 2040 was calculated based on demographic projections. RESULTS: Globally, approximately 573 000 new BCa cases and 213 000 deaths occurred in 2020, corresponding to ASIRs and ASMRs of 5.6 and 1.9 per 100 000, respectively. The incidence and mortality rates were approximately 4-fold higher in men (9.5 and 3.3 per 100 000, respectively) than women (2.4 and 0.9, respectively). Across world regions, incidence rates varied at least 12-fold among men and 8-fold among women, with the highest ASIRs for both men and women detected in Southern Europe (26.5 and 5.8 per 100 000, respectively) and Western Europe (21.5 and 5.8, respectively) and the lowest in Middle Africa (2.2) in men and South-Central Asia (0.7) in women. The highest ASMRs for both men and women were found in Northern Africa (9.2 and 1.8 per 100 000, respectively). By 2040, the annual number of new BCa cases and deaths will increase to 991 000 (72.8% increase from 2020) and 397 000 (86.6% increase), respectively. CONCLUSIONS: Geographical distributions of BCa incidence and mortality uncovered higher risk of BCa incidence in Southern and Western European populations and higher risk of mortality in Northern African populations. Considering the predicted 73% and 87% increase in annual BCa cases and deaths by 2040 globally, respectively, there is an urgent need to develop and accelerate BCa control initiatives for high-risk populations to tackle global BCa burden and narrow its geographical disparities. International Society of Global Health 2023-09-15 /pmc/articles/PMC10502766/ /pubmed/37712386 http://dx.doi.org/10.7189/jogh.13.04109 Text en Copyright © 2023 by the Journal of Global Health. All rights reserved. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Articles
Zhang, Yanting
Rumgay, Harriet
Li, Mengmeng
Yu, Haibing
Pan, Haiyan
Ni, Jindong
The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
title The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
title_full The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
title_fullStr The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
title_full_unstemmed The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
title_short The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
title_sort global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502766/
https://www.ncbi.nlm.nih.gov/pubmed/37712386
http://dx.doi.org/10.7189/jogh.13.04109
work_keys_str_mv AT zhangyanting thegloballandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT rumgayharriet thegloballandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT limengmeng thegloballandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT yuhaibing thegloballandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT panhaiyan thegloballandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT nijindong thegloballandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT zhangyanting globallandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT rumgayharriet globallandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT limengmeng globallandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT yuhaibing globallandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT panhaiyan globallandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040
AT nijindong globallandscapeofbladdercancerincidenceandmortalityin2020andprojectionsto2040